The Effects of Low Concentration Atropine on Pupil Size and Accommodation

Completed · Phase 3

Conditions studied: Myopia

In brief

The purpose of this study is to determine whether less frequent dosing of atropine drops may be as effective as daily dosing for the treatment of progressive myopia.

Key facts

Study ID

NCT02870478

Run by

University of California, Berkeley

People needed

32

Starts

2016-07-01

Expected to finish

2019-11-20

Last updated by the study team

2020-11-04

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants must have vision that is correctable to 20/20 in each eye
• Participants must also have normal binocular vision (no history of manifest eye turns or eye surgeries to correct an eye turn)
• Participants must have normal accommodation (amplitude and facility within a normal range based on the subject's age)
• Participants must have normal ocular health

You may not qualify if…

• Previous chronic use of atropine
• Participants who are pregnant, plan to become pregnant, or are breastfeeding
• Sensitivity or allergy to atropine

Where it is running

• UC Berkeley, Department of Vision Science — Berkeley, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.